amcinonide   Click here for help

GtoPdb Ligand ID: 7060

Synonyms: CL-34699 | Cyclocort®
Approved drug Immunopharmacology Ligand
amcinonide is an approved drug (FDA (1979))
Compound class: Synthetic organic
Comment: A topically applied corticosteroid.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 99.13
Molecular weight 502.24
XLogP 2.34
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES CC(=O)OCC(=O)C12OC3(OC1CC1C2(C)CC(O)C2(C1CCC1=CC(=O)C=CC21C)F)CCCC3
Isomeric SMILES CC(=O)OCC(=O)[C@@]12OC3(O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@]2([C@H]1CCC1=CC(=O)C=C[C@]21C)F)CCCC3
InChI InChI=1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1
InChI Key ILKJAFIWWBXGDU-MOGDOJJUSA-N
No information available.
Summary of Clinical Use Click here for help
Used to treat itching and inflammation associated with allergic and other inflammatory skin conditions.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
When an agonist binds to and activates the glucocorticoid receptor, the activated receptor complex translocates to the nucleus where it transactivates glucocorticoid response element (GRE) containing genes. The effect of glucocorticoid action is to up-regulate expression of anti-inflammatory proteins and to suppress activity of pro-inflammatory proteins, leading to a general suppression of the immune system. However, we have been unable to find affinity data for this drug to substantiate this MMOA.
External links Click here for help
For extended ADME data see the following:

Drugs.com